| Bristol-Myers Squibb Company. (8/3/17). "Press Relase: Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity". New York, NY & Boston, MA. |
2017-08-03 |
| PerkinElmer, Inc.. (8/3/17). "Press Relase: PerkinElmer Announces Financial Results for the Second Quarter of 2017". Waltham, MA. |
2017-08-03 |
| MorphoSys AG. (8/3/17). "Press Relase: MorphoSys Reports Significant Progress in Its Therapeutic Programs in Second Quarter of 2017". Planegg. |
2017-08-03 |
| Medigene AG. (8/3/17). "Press Relase: Medigene Reports Results of First Six Months 2017". Planegg. |
2017-08-03 |
| Merck KGaA. (8/3/17). "Press Relase: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. |
2017-08-03 |
| Merck KGaA. (8/3/17). "Press Relase: Executive Board Changes at Merck". Darmstadt. |
2017-08-03 |
| Merck KGaA. (8/3/17). "Press Relase: Q2 2017 – Merck Sets Course for Future Growth". Darmstadt. |
2017-08-03 |
| Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. |
2017-08-03 |
| Idorsia Ltd.. (8/3/17). "Press Release: Idorsia Announces Half Year Results for 2017 – Successful Start of New Biopharmaceutical Company". Allschwil. |
2017-08-03 |
| Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg. |
2017-08-03 |
| Evotec AG. (8/3/17). "Press Release: Evotec and Fraunhofer IME-SP Sign Strategic Collaboration on iPSC Technology". Hamburg. |
2017-08-03 |
| Bruker Corporation. (8/3/17). "Press Release: Bruker Reports Second Quarter 2017 Financial Results". Billerica, MA. |
2017-08-03 |
| Indivumed GmbH. (8/2/17). "Press Release: MedStar Health Collaborates with Indivumed to Advance Precision Oncology Research". Hamburg. |
2017-08-02 |
| Bruker Corporation. (8/2/17). "Press Release: Bruker Announces Acquisition of Field-portable Platform for Fast and Universal Immunoassay-Detection of Bacteria, Viruses and Toxins". Leipzig. |
2017-08-02 |
| Compugen Ltd.. (8/2/17). "Press Release: Compugen Welcomes Paul Sekhri as its New Chairman of the Board". Holon. |
2017-08-02 |
| High-Tech Gründerfonds Management GmbH. (8/1/17). "Press Release: Specialty Biotech Company Advanced Enzymes Acquires HTGF Portfolio Company Evoxx Technologies". Monheim & Mumbai. |
2017-08-01 |
| Homology Medicines, Inc.. (8/1/17). "Press Release: Homology Medicines Announces $83.5 Million Series B Financing to Advance Lead Development Candidate and AMEnDR In Vivo Gene Editing Technology". Bedford, MA. |
2017-08-01 |
| AiCuris Anti-infective Cures GmbH. (8/1/17). "Press Relase: AiCuris Granted Fast Track Designation by U.S. FDA for Oral Pritelivir for Treatment of HSV Infections in Immunocompromised Adults". Wuppertal. |
2017-08-01 |
| 4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. |
2017-08-01 |
| Valneva S.E.. (8/1/17). "Press Release: Valneva Announces Expansion of its Management Board – Strengthening Senior Management for Future Growth". Lyon. |
2017-08-01 |
| Cluster für Individualisierte ImmunIntervention (Ci3) e. V.. (8/1/17). "Press Release: Collaboration Project between German Biotech and IT Companies Selected for Funding in First PERMIDES Round of Call". |
2017-08-01 |
| CureVac AG. (7/31/17). "Press Release: The 5th International mRNA Health Conference to Showcase Tremendous Advances in the Development of mRNA Drugs". Tübingen & Berlin. |
2017-07-31 |
| Thermo Fisher Scientific Inc.. (7/31/17). "Press Release: Thermo Fisher Scientific Announces Preview of the World's First Fully Integrated LC-MS/MS Clinical Analyzer at AACC 2017". San Diego, CA. |
2017-07-31 |
| Evotec AG. (7/30/17). "Press Release: Evotec to Acquire Aptuit, Expanding Leadership in External Innovation". Hamburg. |
2017-07-30 |
| Evoxx Technologies GmbH. (7/28/17). "Press Release: Specialty Biotech Company Advanced Enzymes Acquires 100% Stake in Evoxx Technologies". Monheim & Mumbai. |
2017-07-28 |
| Idorsia Ltd.. (7/28/17). "Press Release: ACT-541468 (DORA) Meets Primary Endpoint in Phase 2 Program in Adult and Elderly Patients with Insomnia". Allschwil. |
2017-07-28 |
| Evotec AG. (7/27/17). "Press Release: Evotec Expands Collaboration with Storm Therapeutics on Its RNA Epigenetics Platform". Hamburg. |
2017-07-27 |
| High-Tech Gründerfonds Management GmbH. (7/27/17). "Press Release: High-Tech Gründerfonds (HTGF) and MBG invest in stimOS’ Mimicking Bone Technologies. Constance-based Start-Up Company Gains HTGF and MBG as Investors". |
2017-07-27 |
| Proteros Biostructures GmbH. (7/27/17). "Press Release: Proteros Enters into New Research Collaboration with Johnson & Johnson Innovation on Sub-class of Epigenetic targets". Dublin. |
2017-07-27 |
| AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. |
2017-07-27 |
| Eurofins Scientific. (7/27/17). "Press Release: Eurofins Strengthens Its Non-invasive Prenatal Testing Technology Portfolio with the Acquisition of a Majority Stake in LifeCodexx". |
2017-07-27 |
| Qiagen N.V.. (7/27/17). "Press Release: Qiagen Reports Results for Second Quarter and First Half of 2017". Venlo. |
2017-07-27 |
| Boehringer Ingelheim. (7/27/17). "Press Release: Boehringer Ingelheim Starts Clinical Study on Interchangeability between its Adalimumab Biosimilar Candidate and Humira". Ingelheim. |
2017-07-27 |
| Genkyotex S.A.. (7/27/17). "Press Release: Genkyotex Provides Business Update for Q2 2017". Archamps. |
2017-07-27 |
| XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. |
2017-07-26 |
| TxCell S.A.. (7/26/17). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2017". Valbonne. |
2017-07-26 |
| DiaSorin S.p.A.. (7/25/17). "Press Release: DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio and Associated Assets from Siemens Healthineers". Saluggia. |
2017-07-25 |
| Protembis GmbH. (7/25/17). "Press Release: Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion". Aachen & Cambridge, MA. |
2017-07-25 |
| Evotec AG. (7/24/17). "Press Release: Evotec and Bayer Advance Endometriosis Programme into Phase 1 Clinical Development and Extend Alliance". Hamburg. |
2017-07-24 |
| Definiens AG. (7/24/17). "Press Release: Definiens Forearms Organization for Strategic Expansion". Munich. |
2017-07-24 |
| Royal Philips. (7/24/17). "Press Release: Philips' Second Quarter Results 2017". |
2017-07-24 |
| Valneva S.E.. (7/24/17). "Press Release: Valneva Receives FDA Fast Track Designation for Its Lyme Disease Vaccine Candidate VLA15". Lyon. |
2017-07-24 |
| Bayer AG. (7/21/17). "Press Release: Phase II Trial of Investigational Anetumab Ravtansine Does Not Meet Primary Endpoint in Second-Line Mesothelioma [Not intended for U.S. and UK Media]". Berlin. |
2017-07-21 |
| Bayer AG. (7/21/17). "Press Release: Bayer’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation [...] [Not intended for U.S. and UK Media]". Berlin. |
2017-07-21 |
| Vifor Pharma AG. (7/21/17). "Press Release: European Commission Approves Marketing Authorisation for Veltassa". |
2017-07-21 |
| Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA. |
2017-07-20 |
| Spindiag GmbH. (7/20/17). "Press Release: SpinDiag Raises 1.6 Mio EUR Seed-Capital to Bring Its Revolutionary Point-of-Care Screening System for Antibiotic Resistance to Initial Testing in Hospitals". Freiburg. |
2017-07-20 |
| CureVac AG. (7/20/17). "Press Release: CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies". Tübingen. |
2017-07-20 |
| Philogen S.p.A.. (7/20/17). "Press Release: Philogen Enters into Multi-target Research Agreement with Boehringer Ingelheim in the Field of DNA-encoded Chemistry". Siena. |
2017-07-20 |
| Philips. (7/20/17). "Press Release: Chief Business Leader of Philips’ Personal Health Businesses Pieter Nota to Leave Company". Amsterdam. |
2017-07-20 |
| Ionicon Analytik GmbH. (7/20/17). "Press Release: Ionicon Launches AMC-Monitor T-1000 for the Semiconductor Industry". Innsbruck. |
2017-07-20 |
| Basilea Pharmaceutica Ltd.. (7/20/17). "Press Release: Basilea Announces Completion of the License Agreement with Pfizer for Antifungal Cresemba for Europe, Russia, Turkey and Israel". Basel. |
2017-07-20 |
| Sartorius AG. (7/19/17). "Press Release: Sartorius Supervisory Board Elects Dr. Lothar Kappich as Its Chairman". Göttingen. |
2017-07-19 |
| Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva. |
2017-07-18 |
| Agilent Technologies Inc.. (7/18/17). "Press Release: Hans E. Bishop to Join Agilent’s Board of Directors. CEO of Juno Therapeutics Brings Deep Knowledge of the Biopharma Industry". Santa Clara, CA. |
2017-07-18 |
| Royal Philips. (7/18/17). "Press Release: Philips to Strengthen Its Ultrasound Business with the Acquisition of Clinical Applications and Imaging Software Company TomTec". Amsterdam. |
2017-07-18 |
| Humabs BioMed S.A.. (7/18/17). "Press Release: Humabs BioMed and University of California, Berkeley Announce Publication of Data for Novel Antibody-based Assay to Detect Zika Virus Infection". Bellinzona & Berkeley, CA. |
2017-07-18 |
| 4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. |
2017-07-18 |
| Novartis AG. (7/18/17). "Press Release: Q2 Results Confirm Full Year Guidance". Basel. |
2017-07-18 |
| Eurofins Scientific. (7/18/17). "Press Release: Eurofins Issues EUR 650m New Euro Bond". |
2017-07-18 |
| Autolus Therapeutics Ltd.. (7/18/17). "Press Release: Autolus Announces Senior Leadership Appointments". London. |
2017-07-18 |
| BASF SE. (7/17/17). "Press Release: BASF and Kaiima Announce Collaboration to Identify Novel Herbicide Resistance Traits Using the EP Technology Platform". Limburgerhof & Moshav Sharona. |
2017-07-17 |
| Eurofins Scientific. (7/17/17). "Press Release: Eurofins Announces the Potential Launch of a New Senior EUR 500m Bond on the Back of Strong M&A Activity". |
2017-07-17 |
| VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany". |
2017-07-17 |
| Novartis AG. (7/14/17). "Press Release: Novartis Confirms 5 Year Data for First and Only Fully-human IL-17A Inhibitor Cosentyx Reinforcing Sustained Efficacy and Safety Profile in Psoriasis". Basel. |
2017-07-14 |
| PreOmics GmbH. (7/14/17). "Press Release: Diagenode and PreOmics Launch New Streamlined Sample Preparation Solution for Proteomic Analyses". Liège, Denville & Martinsried. |
2017-07-14 |
| Novartis AG. (7/13/17). "Press Release: Novartis CAR-T Cell Therapy CTL019 Unanimously (10-0) Recommended for Approval by FDA Advisory Committee to Treat Pediatric, Young Adult r/r B-cell ALL". Basel. |
2017-07-13 |
| MorphoSys AG. (7/13/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received US FDA Approval for Tremfya (Guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Planegg-Martinsried. |
2017-07-13 |
| BASF SE. (7/13/17). "Press Release: BASF Introduces First New Class of Public Health Insecticide for Malaria Prevention in more than 30 Years". Limburgerhof. |
2017-07-13 |
| Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich. |
2017-07-13 |
| Johnson & Johnson Inc.. (7/13/17). "Press Release: Janssen Announces U.S. FDA Approval of Tremfya (guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Horsham, PA. |
2017-07-13 |
| Epigenomics AG. (7/12/17). "Press Release: Epigenomics AG – Voluntary Public Takeover Offer by Summit Hero Holding Not Successful". Berlin. |
2017-07-12 |
| Merck KGaA. (7/12/17). "Press Relase: Merck Refines Western European Life Science Production Site Network". Darmstadt. |
2017-07-12 |
| Creathor Venture Management GmbH. (7/11/17). "Press Release: Creathor Venture Invests in AI-enabled Clinical Genetic Testing Company Blueprint Genetics as Part of an up to EUR 14 Million Financing Round". Bad Homburg v. d. H.. |
2017-07-11 |
| Numares AG. (7/11/17). "Press Release: Numares AG Achieves Key Milestone – Identifies Candidate Metabolomic Network for Bladder Cancer Diagnostics". Regensburg. |
2017-07-11 |
| Genedata AG. (7/11/17). "Press Release: Genedata Selector Expands Partnership with AB Enzymes". Basel. |
2017-07-11 |
| Enterome S.A.. (7/11/17). "Press Release: Enterome and Nestlé Health Sciences Launch New Diagnostics Company". Paris. |
2017-07-11 |
| Noxxon Pharma N.V.. (7/11/17). "Press Release: Noxxon Pharma Announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the EuroNext Growth Market". Berlin. |
2017-07-11 |
| Silence Therapeutics plc. (7/10/17). "Press Release: IP Update". |
2017-07-10 |
| CRISPR Therapeutics AG. (7/10/17). "Press Release: CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration". Cambridge, MA & Basel. |
2017-07-10 |
| Phenex Pharmaceuticals AG. (7/10/17). "Press Release: Phenex AG Announces Milestone Payment from Janssen for the Entry of RORgt Inhibitor into Phase I". Ludwigshafen. |
2017-07-10 |
| Stada Arzneimittel AG. (7/10/17). "Press Release: Stada Supports Renewed Improved Takeover Offer Announced by Bain Capital and Cinven". Bad Vilbel. |
2017-07-10 |
| Curetis N.V.. (7/7/17). "Press Release: Curetis to Attend Key Investor and Scientific Conferences in the Third Quarter 2017". Amsterdam & Holzgerlingen. |
2017-07-07 |
| Evotec AG. (7/6/17). "Press Release: Evotec Received Funding from IFB Hamburg to Identify Antibody-mediated T-Cell Immunotherapies". Hamburg. |
2017-07-06 |
| Epigenomics AG. (7/6/17). "Press Release: Epigenomics AG Issues Change in Guidance for Financial Year 2017". |
2017-07-06 |
| 4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. |
2017-07-06 |
| Evolva Holding S.A.. (7/6/17). "Press Release: Neil Goldsmith Stepping Down as CEO and Board Member of Evolva". |
2017-07-06 |
| Oxford Biomedica plc. (7/6/17). "Press Release: Oxford BioMedica Announces a Major Supply Agreement". Oxford. |
2017-07-06 |
| Lonza Group Ltd.. (7/6/17). "Press Release: Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel. |
2017-07-06 |
| CRISPR Therapeutics AG. (7/5/17). "Press Release: CRISPR Therapeutics to Present at the Piper Jaffray GenomeRx Symposium". Basel & Cambridge, MA. |
2017-07-05 |
| Horizon Discovery Group plc. (7/5/17). "Press Release: Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform". Cambridge. |
2017-07-05 |
| Seventure Partners. (7/5/17). "Press Release: Health for Life Capital Participates in $13.2m Financing of Japanese Microbiome Leader Anaeropharma Science". Paris. |
2017-07-05 |
| Roche Diagnostics GmbH. (7/5/17). "Pressemitteilung: Roche weiht Neubauten des Biotechnologie-Zentrums in Penzberg ein. Investitionen am Roche Standort Penzberg von 600 Millionen Euro". Penzberg. |
2017-07-05 |
| Eurofins Scientific. (7/4/17). "Press Release: Eurofins Announces AOAC and AFNOR Certification for BACGene and BACSpec Listeria Kits". |
2017-07-04 |
| Noxxon Pharma N.V.. (7/4/17). "Press Release: Noxxon Announces First Patients Treated in Phase I/II Clinical Trial of NOX-A12 Combined with Keytruda in Metastatic Pancreatic and Colorectal Cancer". Berlin. |
2017-07-04 |
| Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. |
2017-07-03 |
| Silence Therapeutics plc. (7/3/17). "Press Release: Change of Adviser". |
2017-07-03 |
| Silence Therapeutics plc. (7/3/17). "Press Release: Issue of Claim in the UK High Courts". |
2017-07-03 |
| Analytik Jena AG. (6/30/17). "Press Release: Analytik Jena Sells AJ Blomesystem". Jena & Cologne. |
2017-06-30 |
| Oxford Biomedica plc. (6/30/17). "Press Release: Oxford BioMedica Announces Refinancing of Debt Facility". London. |
2017-06-30 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 31 32 33 ... 44 45 46 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
